Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Preoperative ofloxacin minimizes conjunctival bacterial flora
Stanford, CA-Topical ofloxacin 0.3% (Ocuflox, Allergan) treatment for 3 days preoperatively is more effective than a short-course on the day of surgery alone for reducing conjunctival bacterial load during the perioperative period, said Christopher N. Ta, MD.
Related Videos
Related Content
